Kadmon Holdings Inc KDMN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/23/21 EDT
4.21UNCH (UNCH)
Volume
19,289
Close
4.21quote price arrow down-0.11 (-2.55%)
Volume
3,292,720
52 week range
3.15 - 5.73

...

Loading . . .
  • Open4.21
  • Day High4.31
  • Day Low4.19
  • Prev Close4.32
  • 52 Week High5.73
  • 52 Week High Date02/05/21
  • 52 Week Low3.15
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap723.99M
  • Shares Out171.97M
  • 10 Day Average Volume7.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change1.45

KEY STATS

  • Open4.21
  • Day High4.31
  • Day Low4.19
  • Prev Close4.32
  • 52 Week High5.73
  • 52 Week High Date02/05/21
  • 52 Week Low3.15
  • 52 Week Low Date11/02/20
  • Market Cap723.99M
  • Shares Out171.97M
  • 10 Day Average Volume7.47M
  • Dividend-
  • Dividend Yield-
  • Beta1.55
  • YTD % Change1.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.66
  • P/E (TTM)-6.41
  • Fwd P/E (NTM)-5.94
  • EBITDA (MRQ)-111.923M
  • ROE (MRQ)-200.40%
  • Revenue (MRQ)2.12M
  • Gross Margin (MRQ)29.82%
  • Net Margin (MRQ)-5,103.69%
  • Debt To Equity (MRQ)397.96%

EVENTS

  • Earnings Date08/07/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kadmon Holdings Inc

There is no recent news for this security.

Profile

MORE
Kadmon Holdings, Inc. is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. Its product pipeline consists of KD025, Tesevatinib and KD034. The Company's other products include Ribasphere RibaPak...
Tasos Konidaris
Non-Executive Chairman
Harlan Waksal M.D.
President
Steven Meehan
Chief Financial Officer
Gregory Moss Esq.
Executive Vice President
John Ryan M.D., Ph.D.
Executive Vice President
Address
450 E 29th St
New York, NY
10016
United States

Top Peers

SYMBOLLASTCHG%CHG
SNDX
Syndax Pharmaceuticals Inc
14.26-0.44-2.99%
RAPT
Rapt Therapeutics Inc
32.17+0.02+0.06%
ORIC
Oric Pharmaceuticals Inc
17.25-0.46-2.60%
AKRO
Akero Therapeutics Inc
22.37-0.60-2.61%
ACRS
Aclaris Therapeutics Inc
15.70+0.09+0.58%